[ad_1]
the health
Reuters
“The Economic Times” newspaper reported that the South African authorities had requested the Indian Serum Institute to collect one million doses of the “AstraZeneca” anti-Corona vaccine, which were delivered to the republic at the beginning of this month.
read more
The newspaper wrote that the country’s authorities took this decision after scientists announced the low effectiveness of this vaccine in combating the local strain of Corona.
And previously media outlets reported that the Republic of South Africa decided to stop implementing the plan to vaccinate its citizens using the “AstraZeneca” vaccine and replace it with a vaccine manufactured by “Johnson & Johnson”.
The head of the WHO’s strategic advisory group on vaccination, Alejandro Craviotto, said that it is recommended that the “AstraZeneca” vaccine be used in countries where new strains of the Coronavirus are widespread. However, the results of preliminary research conducted by a group of scientists showed that the effectiveness of this vaccine against the “South African strain” is low.
The “South African strain” of Coronavirus (501.V2) was found for the first time in the Republic of South Africa last October, and it has become the most prevalent in this country. And introductory information indicates that it is more contagious.
Source: Novosti
[ad_2]
Source link